can you lose weight on tirzepatide 2.5 mg How Much with of Mounjaro? Mounjaro (tirzepatide) - Diabetes &

Demand for Mounjaro & Zepbound continues to drive revenue EPS growth expected +441.5% YoY this quarter Shares up +14.4% in the past month Strong contributions from new drugs like Kisunla, Omvoh, and Jaypirca With rapid expansion in obesity and diabetes treatments, LLYs momentum shows no signs of slowing

The more surface area you have, the more rotation options you get, and the less likely you are to develop tissue damage from overuse

The benefit-risk profile of our GLP-1 medicines remains positive, and we welcome any new research that will improve our understanding of treatments for people living with chronic diseases.

These include poor diet, toxins, medications, radiation, physical and mental stress and ageing

Acknowledgements The staff at Hedenstierna lab (Uppsala University), the Preclinical PET- MRI Platform (PPP) (Uppsala University), and the Akademiska Sju- khuset PET centre (Uppsala University Hospital) are acknowledged for excellent technical assistance